Graves' Dermopathy and Acropachy Are Markers of Severe Graves' Ophthalmopathy

Thyroid

Volumn 13, Issue 12, 2003, Pages 1141-1144

  Fatourechi, Vahab ^a   Bartley, George B ^a   Eghbali Fatourechi, Guiti Z ^a   Powell, Claudia C ^a   Ahmed, Debra D F ^a   Garrity, James A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; ENDOCRINE OPHTHALMOPATHY; FEMALE; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPTIC NERVE DISEASE; ORBIT DISEASE; PRIORITY JOURNAL; SKIN DISEASE;

EID: 0347363463     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/10507250360731541     Document Type: Article

References (23)

1. Weetman AP 1993 Extrathyroidal complications of Graves' disease. Q J Med 86:473-477.
2. Wortsman J 1996 Graves' dermopathy [letter]. Thyroid 6:655-657.
3. Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, Gorman CA 1995 The incidence of Graves' ophthalmopathy in Olmsted County, Minnesota. Am J Ophthalmol 120:511-517.
4. Bartley GB 1994 The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota. Trans Am Ophthalmol Soc 92:477-588.
5. Fatourechi V, Pajouhi M, Fransway AF 1994 Dermopathy of Graves disease (pretibial myxedema): Review of 150 cases. Medicine (Baltimore) 73:1-7.
6. Schwartz KM, Fatourechi V, Ahmed DD, Pond GR 2002 Dermopathy of Graves' disease (pretibial myxedema): Long-term outcome. J Clin Endocrinol Metab 87:438-446.
7. Ellis JG 1975 Thyroid acropachy. IMJ III Med J 147:149-150, 153.
8. Goette DK 1980 Thyroid acropachy. Arch Dermatol 116:205-206.
9. Kinsella RA Jr, Back DK 1968 Thyroid acropachy. Med Clin North Am 52:393-398.
10. Winkler A, Wilson D 1985 Thyroid acropachy: Case report and literature review. Mo Med 82:756-761.
11. McCarthy J, Twersky J, Lion M 1975 Thyroid acropachy. J Can Assoc Radiol 26:199-202.
12. Fatourechi V, Ahmed DD, Schwartz KM 2002 Thyroid acropachy: Report of 40 patients treated at a single institution in a 26-year period. J Clin Endocrinol Metab 87:5435-5441.
13. Fatourechi V 2000 Graves' disease: Localized myxedema and thyroid acropachy. In: Braverman LE, Utiger RD (eds) Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text, 8th ed. Philadelphia: Lippincott Williams & Wilkins, p. 549.
14. Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, Gorman CA 1996 Clinical features of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol 121:284-290.
15. Bartley GB, Gorman CA 1995 Diagnostic criteria for Graves' ophthalmopathy. Am J Ophthalmol 119:792-795.
16. Garrity JA, Fatourechi V, Bergstralh EJ, Bartley GB, Beatty CW, DeSanto LW, Gorman CA 1993 Results of transantral orbital decompression in 428 patients with severe Graves' ophthalmopathy. Am J Ophthalmol 116:533-547.
17. Fatourechi V, Bergstralh EJ, Garrity JA, Bartley GB, Beatty CW, Offord KP, Gorman CA 1994 Predictors of response to transantral orbital decompression in severe Graves' ophthalmopathy. Mayo Clin Proc 69:841-848.
18. Fatourechi V, Bartley GB, Garrity JA, Bergstralh EJ, Ebersold MJ, Gorman CA 1993 Transfrontal orbital decompression after failure of transantral decompression in optic neuropathy of Graves' disease. Mayo Clin Proc 68:552-555.
19. Fatourechi V, Garrity JA, Bartley GB, Bergstralh EJ, Gorman CA 1993 Orbital decompression in Graves' ophthalmopathy associated with pretibial myxedema. J Endocrinol Invest 16:433-437.
20. Wiersinga WM, Smit T, van der Gaag R, Koornneef L 1988 Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease. J Endocrinol Invest 11:615-619.
21. Morris JC III, Hay ID, Nelson RE, Jiang NS 1988 Clinical utility of thyrotropin-receptor antibody assays: Comparison of radioreceptor and bioassay methods. Mayo Clin Proc 63:707-717.
22. Gerding MN, van der Meer JW, Broenink M, Bakker O, Wiersinga WM, Prummel MF 2000 Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clin Endocrinol (Oxf) 52:267-271.
23. Georgala S, Katoulis AC, Georgala C, Katoulis EC, Hatziolou E, Stavrianeas NG 2002 Pretibial myxedema as the initial manifestation of Graves' disease. J Eur Acad Dermatol Venereol 16:380-383.